Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28910
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVerberne, Anthony J M-
dc.contributor.authorMussa, Bashair M-
dc.date2022-02-18-
dc.date.accessioned2022-03-01T04:43:53Z-
dc.date.available2022-03-01T04:43:53Z-
dc.date.issued2022-06-
dc.identifier.citationPeptides 2022; 152: 170768en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28910-
dc.description.abstractPancreatic peptide hormone secretion is inextricably linked to maintenance of normal levels of blood glucose. In animals and man, pancreatic peptide hormone secretion is controlled, at least in part, by input from parasympathetic (vagal) premotor neurons that are found principally in the dorsal motor nucleus of the vagus (DMV). Iatrogenic (insulin-induced) hypoglycaemia evokes a homeostatic response commonly referred to as the glucose counter-regulatory response. This homeostatic response is of particular importance in Type 1 diabetes in which episodes of hypoglycaemia are common, debilitating and lead to suboptimal control of blood glucose. Glucagon is the principal counterregulatory hormone but for reasons unknown, its secretion during insulin-induced hypoglycaemia is impaired. Pancreatic parasympathetic neurons are distinguishable electrophysiologically from those that control other (e.g. gastric) functions and are controlled by supramedullary inputs from hypothalamic structures such as the perifornical region. During hypoglycaemia, glucose-sensitive, GABAergic neurons in the ventromedial hypothalamus are inhibited leading to disinhibition of perifornical orexin neurons with projections to the DMV which, in turn, leads to increased secretion of glucagon.en
dc.language.isoeng-
dc.subjectGlucagonen
dc.subjectGlycaemiaen
dc.subjectInsulinen
dc.subjectPancreasen
dc.subjectParasympatheticen
dc.titleNeural control of pancreatic peptide hormone secretion.en
dc.typeJournal Articleen
dc.identifier.journaltitlePeptidesen
dc.identifier.affiliationMedicine (University of Melbourne)en
dc.identifier.affiliationBasic Medical Science Department, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates..en
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35189258/en
dc.identifier.doi10.1016/j.peptides.2022.170768en
dc.type.contentTexten
dc.identifier.orcid0000-0002-2049-1439en
dc.identifier.pubmedid35189258-
local.name.researcherVerberne, Anthony J M
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptClinical Pharmacology and Therapeutics-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Nov 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.